Healthcare Costs of Long-Acting Insulin Analogs vs NPH Insulin in Type 2 Diabetes Patients Using a Basal Regimen in Denmark

被引：0
|
作者：
Gundgaard, Jens
Aagren, Mark
Thomsen, Trine L.
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A316 / A317
页数：2
相关论文
共 50 条
  • [21] Comparative Effectiveness of Long-Acting Insulin Analogs and Neutral Protamine Hagedorn (nph) Insulin for the Reduction of Major Adverse Cardiovascular Events Among Patients With Type 2 Diabetes
    Brunetti, Vanessa C. C.
    Yu, Oriana H.
    Platt, Robert W.
    Filion, Kristian B.
    CIRCULATION, 2021, 144
  • [22] (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
    Semlitsch, Thomas
    Engler, Jennifer
    Siebenhofer, Andrea
    Jeitler, Klaus
    Berghold, Andrea
    Horvath, Karl
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (11):
  • [23] Long-Acting Insulin Analogs: A Review of "Real-World" Effectiveness in Patients with Type 2 Diabetes
    Pollock, Richard F.
    Erny-Albrecht, Katrina M.
    Kalsekar, Anupama
    Bruhn, David
    Valentine, William J.
    CURRENT DIABETES REVIEWS, 2011, 7 (01) : 61 - 74
  • [24] INSULIN GLARGINE AND NPH INSULIN-BASED REGIMENS REVEAL COMPARABLE TOTAL DIRECT TREATMENT COSTS IN TYPE 2 DIABETES PATIENTS. THE LONG-ACTING INSULIN GLARGINE VS. NPH INSULIN COST EVALUATION STUDY IN GERMANY (LIVE-DE)
    Scholten, T.
    Holle, R.
    Landgraf, W.
    Spiesecke, A.
    Hauner, H.
    VALUE IN HEALTH, 2008, 11 (06) : A504 - A504
  • [25] Synthetic long-acting insulin analogs for the management of type 1 diabetes: an update
    Pedersen-Bjergaard, Ulrik
    Fabricius, Therese W.
    Thorsteinsson, Birger
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (16) : 2251 - 2259
  • [26] Beyond the era of NPH insulin - Long-acting insulin analogs: Chemistry, comparative pharmacology, and clinical application
    Owens, D. R.
    Biol, F. I.
    Bolli, G. B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (05) : 333 - 349
  • [27] Efficacy of Rapid-Acting and Long-Acting Insulin Analogs in Japanese Patients with Type 1 Diabetes Mellitus
    Ozaki, Nobuaki
    Nomura, Yoshio
    Wanibe, Harumatsu
    Yamamori, Ikuo
    Oiso, Yutaka
    DIABETES, 2009, 58 : A524 - A524
  • [28] Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes
    Schmid, C.
    Krayenbuhl, P.
    Wiesli, P.
    DIABETOLOGIA, 2009, 52 (12) : 2668 - 2669
  • [29] Long-acting basal insulin analogs: latest developments and clinical usefulness
    Mavrogiannaki, Anastasia N.
    Migdalis, Ilias N.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2012, 3 (06) : 249 - 257
  • [30] The utilisation of long-acting insulin analogues and intermediate-acting insulin in patients with type 2 diabetes in the United Kingdom
    Brunetti, V. C.
    Yu, O. H. Y.
    Platt, R. W.
    Filion, K. B.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S146 - S146
12345